Vivimed Labs moves higher on acquiring 100% equity stake in Klar Sehen

Vivimed Labs is currently trading at Rs. 245.45, up by 1.00 points or 0.41% from its previous closing of Rs. 244.45 on the BSE.

The scrip opened at Rs. 243.00 and has touched a high and low of Rs. 252.90 and Rs. 242.10 respectively. So far 54515 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 350.00 on 01-Oct-2010 and a 52 week low of Rs. 216.00 on 10-Feb-2011.

Last one week high and low of the scrip stood at Rs. 252.90 and Rs. 230.00 respectively. The current market cap of the company is Rs. 304.19 crore.

The promoters holding in the company stood at 49.84% while Institutions and Non-Institutions held 6.66% and 43.51% respectively. 

Vivimed Labs, in a bid to consolidate its segment of domestic pharmaceutical business, has acquired 100% equity stake in Klar Sehen (KSPL).  Vivimed's acquisition of KSPL complements its strategy to increase its domestic presence in specialty pharmaceutical areas, its extensive knowledge and experience in manufacturing, R&D will help grow this business to new levels.

KSPL is a 30 year old Kolkata based Pharmaceutical Company with strong marketing presence in North East, Bihar and Andhra Pradesh. KSPL operates in a niche ophthalmic segment and owns about 50 trademarks and some very well known brands such as Renicol, Lysicon-V, Care Tears, Dexacort etc, in eye care segment. KSPL has cGMP compliant manufacturing facilities at Kolkata, Hyderabad and also has arrangements to manufacture some of its products in Uttaranchal. KSPL presently operates from its headquarters in Kolkata with over 150 medical sales professionals.

In a research conducted by C-Marc (India) for the period Nov-Feb 2011, KSPL for its wide range of Ophthalmic products has bagged an all India corporate standing rank of no 1 in the East Zone and bagged a rank of no 5 in India (in Indian, Dist HQ & Extra-Urban and rural markets).

Vivimed Labs is engaged in the business of manufacturing ingredients for the home and personal care (H&PC) industry and Contract Research and Manufacturing Services (CRAMS). It carries on its business from 4 manufacturing facilities which are located at Bidar (Karnataka), Jeedimetla (Hyderabad), Bonthapally (Hyderabad) and Kashipur (Uttaranchal).